These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34130872)

  • 1. Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374-82.
    Liu W; Zukotynski K; Bauman G
    Eur Urol; 2021 Sep; 80(3):e77-e78. PubMed ID: 34130872
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Wei Liu, Katherine Zukotynski, and Glenn Bauman's Letter to the Editor re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374-82.
    Glicksman RM; Berlin A
    Eur Urol; 2021 Sep; 80(3):e79-e80. PubMed ID: 34158186
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62: Comorbidity Measurement in Patients with Prostate Cancer.
    Froehner M; Koch R; Graefen M
    Eur Urol; 2021 May; 79(5):e138. PubMed ID: 33612374
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Zhou X; Han X
    Eur Urol; 2019 Jul; 76(1):e15. PubMed ID: 30948226
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Van den Broeck T; Mottet N; Lam T
    Eur Urol; 2019 Jul; 76(1):e16. PubMed ID: 30967298
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate Cancer.
    van den Bergh RCN; O'Hanlon S; Cornford P; Mottet N;
    Eur Urol; 2021 May; 79(5):e139-e140. PubMed ID: 33608157
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871.
    Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Montorsi F; Montironi R
    Eur Urol; 2020 May; 77(5):e122-e127. PubMed ID: 32089357
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Marcin Miszczyk, Pawel Rajawa, Takafumi Yanagisawa, et al. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol. 2024;85:125-38.
    Fodor A; Brombin C; Chiti A; Di Muzio N
    Eur Urol; 2024 Oct; 86(4):e93-e94. PubMed ID: 38480110
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. Eur Urol 2019;76:732-9.
    Ghadjar P; Wiegel T
    Eur Urol; 2020 Mar; 77(3):e60-e61. PubMed ID: 31744642
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.
    Sighinolfi MC; Rocco B
    Eur Urol; 2020 May; 77(5):e128-e129. PubMed ID: 32067794
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Gregucci F; Carbonara R; Fiorentino A
    Eur Urol; 2020 Sep; 78(3):e114-e115. PubMed ID: 32534911
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Funada S; Yoshioka T; Luo Y
    Eur Urol; 2020 Sep; 78(3):e118-e119. PubMed ID: 32682614
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Montorsi F; Salonia A; Briganti A
    Eur Urol; 2020 Nov; 78(5):e192. PubMed ID: 32800728
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Aurélie De Bruycker, Elise De Bleser, Karel Decaestecker, et al. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. Eur Urol 2019;75:826-33: Nodal Recurrence of Prostate Cancer in Patients Treated with Radical Intent: Tailoring the Best Salvage Treatment.
    Montorsi F; Fossati N; Gandaglia G; Briganti A
    Eur Urol; 2020 May; 77(5):e137. PubMed ID: 32037141
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Pirus Ghadjar, Thomas Wiegel's Letter to the Editor re: Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome, Toxicity of Stereotactic Body Radiotherapy, Elective Nodal Radiotherapy. Eur Urol 2019;76:732-9.
    De Bleser E; Ost P
    Eur Urol; 2020 Mar; 77(3):e62-e63. PubMed ID: 31744645
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
    Pontes-Silva A
    Eur Urol; 2024 Feb; 85(2):e43-e44. PubMed ID: 37758572
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
    May M; Wolff I; Brookman-May SD
    Eur Urol; 2024 Feb; 85(2):e47-e48. PubMed ID: 37743196
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. 2023;83:561-70.
    Mai Z; Yan W; Zhou Z
    Eur Urol; 2023 Aug; 84(2):e46-e47. PubMed ID: 37244814
    [No Abstract]   [Full Text] [Related]  

  • 20. [
    Glicksman RM; Metser U; Valliant J; Chung PW; Fleshner NE; Bristow RG; Green D; Finelli A; Hamilton R; Stanescu T; Hussey D; Catton C; Gospodarowicz M; Warde P; Bayley A; Breen S; Vines D; Jaffray DA; Berlin A
    BMJ Open; 2020 Apr; 10(4):e035959. PubMed ID: 32327479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.